Industry: Chemical & Material
Published Date: 2025-02-28
Pages: 124 Pages
Report ld: 4349665
Request Sample
Customized Report
Montelukast Sodium Intermediates Market Size(US$)

CAGR 2025-2031
9.7%
Market Size,2031
USD 4,118
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Montelukast Sodium Intermediates was valued at US$ 2154 million in the year 2024 and is projected to reach a revised size of US$ 4118 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Montelukast sodium intermediate is one of the key raw materials used in the production of Montelukast sodium. Montelukast sodium is a drug commonly used to treat allergic asthma and seasonal allergic rhinitis, and belongs to the class of leukotriene receptor antagonists. It mainly blocks the effects of leukotrienes to reduce allergic reactions, thereby relieving asthma symptoms.
North American market for Montelukast Sodium Intermediates is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Montelukast Sodium Intermediates is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Montelukast Sodium Intermediates include Manus Aktteva Biopharma, Ortin Laboratories, PGShah & Co, VIVAN Life Sciences, Arch Pharmalabs, Actis Generics, Morepen Laboratories, TAPI, MSN Laboratories, Ultratech India, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Montelukast Sodium Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Montelukast Sodium Intermediates.
The Montelukast Sodium Intermediates market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Montelukast Sodium Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Montelukast Sodium Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Montelukast Sodium Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Montelukast Sodium Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Montelukast Sodium Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Montelukast Sodium Intermediates Market Overview
1.1 Product Definition
1.2 Montelukast Sodium Intermediates by Type
1.2.1 Global Montelukast Sodium Intermediates Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Aromatic Amines
1.2.3 Ethers
1.2.4 Esters
1.2.5 Others
1.3 Montelukast Sodium Intermediates by Application
1.3.1 Global Montelukast Sodium Intermediates Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Montelukast Sodium Intermediates Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Montelukast Sodium Intermediates Production Estimates and Forecasts (2020-2031)
1.4.4 Global Montelukast Sodium Intermediates Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Montelukast Sodium Intermediates Production Market Share by Manufacturers (2020-2025)
2.2 Global Montelukast Sodium Intermediates Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Montelukast Sodium Intermediates, Industry Ranking, 2023 VS 2024
2.4 Global Montelukast Sodium Intermediates Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Montelukast Sodium Intermediates Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Montelukast Sodium Intermediates, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Montelukast Sodium Intermediates, Product Offered and Application
2.8 Global Key Manufacturers of Montelukast Sodium Intermediates, Date of Enter into This Industry
2.9 Montelukast Sodium Intermediates Market Competitive Situation and Trends
2.9.1 Montelukast Sodium Intermediates Market Concentration Rate
2.9.2 Global 5 and 10 Largest Montelukast Sodium Intermediates Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Montelukast Sodium Intermediates Production by Region
3.1 Global Montelukast Sodium Intermediates Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Montelukast Sodium Intermediates Production Value by Region (2020-2031)
3.2.1 Global Montelukast Sodium Intermediates Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Montelukast Sodium Intermediates by Region (2026-2031)
3.3 Global Montelukast Sodium Intermediates Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Montelukast Sodium Intermediates Production Volume by Region (2020-2031)
3.4.1 Global Montelukast Sodium Intermediates Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Montelukast Sodium Intermediates by Region (2026-2031)
3.5 Global Montelukast Sodium Intermediates Market Price Analysis by Region (2020-2025)
3.6 Global Montelukast Sodium Intermediates Production and Value, Year-over-Year Growth
3.6.1 North America Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Montelukast Sodium Intermediates Production Value Estimates and Forecasts (2020-2031)
4 Montelukast Sodium Intermediates Consumption by Region
4.1 Global Montelukast Sodium Intermediates Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Montelukast Sodium Intermediates Consumption by Region (2020-2031)
4.2.1 Global Montelukast Sodium Intermediates Consumption by Region (2020-2025)
4.2.2 Global Montelukast Sodium Intermediates Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Montelukast Sodium Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Montelukast Sodium Intermediates Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Montelukast Sodium Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Montelukast Sodium Intermediates Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Montelukast Sodium Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Montelukast Sodium Intermediates Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Montelukast Sodium Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Montelukast Sodium Intermediates Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Montelukast Sodium Intermediates Production by Type (2020-2031)
5.1.1 Global Montelukast Sodium Intermediates Production by Type (2020-2025)
5.1.2 Global Montelukast Sodium Intermediates Production by Type (2026-2031)
5.1.3 Global Montelukast Sodium Intermediates Production Market Share by Type (2020-2031)
5.2 Global Montelukast Sodium Intermediates Production Value by Type (2020-2031)
5.2.1 Global Montelukast Sodium Intermediates Production Value by Type (2020-2025)
5.2.2 Global Montelukast Sodium Intermediates Production Value by Type (2026-2031)
5.2.3 Global Montelukast Sodium Intermediates Production Value Market Share by Type (2020-2031)
5.3 Global Montelukast Sodium Intermediates Price by Type (2020-2031)
6 Segment by Application
6.1 Global Montelukast Sodium Intermediates Production by Application (2020-2031)
6.1.1 Global Montelukast Sodium Intermediates Production by Application (2020-2025)
6.1.2 Global Montelukast Sodium Intermediates Production by Application (2026-2031)
6.1.3 Global Montelukast Sodium Intermediates Production Market Share by Application (2020-2031)
6.2 Global Montelukast Sodium Intermediates Production Value by Application (2020-2031)
6.2.1 Global Montelukast Sodium Intermediates Production Value by Application (2020-2025)
6.2.2 Global Montelukast Sodium Intermediates Production Value by Application (2026-2031)
6.2.3 Global Montelukast Sodium Intermediates Production Value Market Share by Application (2020-2031)
6.3 Global Montelukast Sodium Intermediates Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Manus Aktteva Biopharma
7.1.1 Manus Aktteva Biopharma Montelukast Sodium Intermediates Company Information
7.1.2 Manus Aktteva Biopharma Montelukast Sodium Intermediates Product Portfolio
7.1.3 Manus Aktteva Biopharma Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Manus Aktteva Biopharma Main Business and Markets Served
7.1.5 Manus Aktteva Biopharma Recent Developments/Updates
7.2 Ortin Laboratories
7.2.1 Ortin Laboratories Montelukast Sodium Intermediates Company Information
7.2.2 Ortin Laboratories Montelukast Sodium Intermediates Product Portfolio
7.2.3 Ortin Laboratories Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Ortin Laboratories Main Business and Markets Served
7.2.5 Ortin Laboratories Recent Developments/Updates
7.3 PGShah & Co
7.3.1 PGShah & Co Montelukast Sodium Intermediates Company Information
7.3.2 PGShah & Co Montelukast Sodium Intermediates Product Portfolio
7.3.3 PGShah & Co Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.3.4 PGShah & Co Main Business and Markets Served
7.3.5 PGShah & Co Recent Developments/Updates
7.4 VIVAN Life Sciences
7.4.1 VIVAN Life Sciences Montelukast Sodium Intermediates Company Information
7.4.2 VIVAN Life Sciences Montelukast Sodium Intermediates Product Portfolio
7.4.3 VIVAN Life Sciences Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.4.4 VIVAN Life Sciences Main Business and Markets Served
7.4.5 VIVAN Life Sciences Recent Developments/Updates
7.5 Arch Pharmalabs
7.5.1 Arch Pharmalabs Montelukast Sodium Intermediates Company Information
7.5.2 Arch Pharmalabs Montelukast Sodium Intermediates Product Portfolio
7.5.3 Arch Pharmalabs Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Arch Pharmalabs Main Business and Markets Served
7.5.5 Arch Pharmalabs Recent Developments/Updates
7.6 Actis Generics
7.6.1 Actis Generics Montelukast Sodium Intermediates Company Information
7.6.2 Actis Generics Montelukast Sodium Intermediates Product Portfolio
7.6.3 Actis Generics Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Actis Generics Main Business and Markets Served
7.6.5 Actis Generics Recent Developments/Updates
7.7 Morepen Laboratories
7.7.1 Morepen Laboratories Montelukast Sodium Intermediates Company Information
7.7.2 Morepen Laboratories Montelukast Sodium Intermediates Product Portfolio
7.7.3 Morepen Laboratories Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Morepen Laboratories Main Business and Markets Served
7.7.5 Morepen Laboratories Recent Developments/Updates
7.8 TAPI
7.8.1 TAPI Montelukast Sodium Intermediates Company Information
7.8.2 TAPI Montelukast Sodium Intermediates Product Portfolio
7.8.3 TAPI Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.8.4 TAPI Main Business and Markets Served
7.8.5 TAPI Recent Developments/Updates
7.9 MSN Laboratories
7.9.1 MSN Laboratories Montelukast Sodium Intermediates Company Information
7.9.2 MSN Laboratories Montelukast Sodium Intermediates Product Portfolio
7.9.3 MSN Laboratories Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.9.4 MSN Laboratories Main Business and Markets Served
7.9.5 MSN Laboratories Recent Developments/Updates
7.10 Ultratech India
7.10.1 Ultratech India Montelukast Sodium Intermediates Company Information
7.10.2 Ultratech India Montelukast Sodium Intermediates Product Portfolio
7.10.3 Ultratech India Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Ultratech India Main Business and Markets Served
7.10.5 Ultratech India Recent Developments/Updates
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Montelukast Sodium Intermediates Company Information
7.11.2 Aurobindo Pharma Montelukast Sodium Intermediates Product Portfolio
7.11.3 Aurobindo Pharma Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Aurobindo Pharma Main Business and Markets Served
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.12 Medopharm
7.12.1 Medopharm Montelukast Sodium Intermediates Company Information
7.12.2 Medopharm Montelukast Sodium Intermediates Product Portfolio
7.12.3 Medopharm Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Medopharm Main Business and Markets Served
7.12.5 Medopharm Recent Developments/Updates
7.13 Nenter & Co., Inc
7.13.1 Nenter & Co., Inc Montelukast Sodium Intermediates Company Information
7.13.2 Nenter & Co., Inc Montelukast Sodium Intermediates Product Portfolio
7.13.3 Nenter & Co., Inc Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Nenter & Co., Inc Main Business and Markets Served
7.13.5 Nenter & Co., Inc Recent Developments/Updates
7.14 Ruiweier Biotechnology
7.14.1 Ruiweier Biotechnology Montelukast Sodium Intermediates Company Information
7.14.2 Ruiweier Biotechnology Montelukast Sodium Intermediates Product Portfolio
7.14.3 Ruiweier Biotechnology Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Ruiweier Biotechnology Main Business and Markets Served
7.14.5 Ruiweier Biotechnology Recent Developments/Updates
7.15 Arromax Pharmatech
7.15.1 Arromax Pharmatech Montelukast Sodium Intermediates Company Information
7.15.2 Arromax Pharmatech Montelukast Sodium Intermediates Product Portfolio
7.15.3 Arromax Pharmatech Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Arromax Pharmatech Main Business and Markets Served
7.15.5 Arromax Pharmatech Recent Developments/Updates
7.16 Alpha Pharmaceutical
7.16.1 Alpha Pharmaceutical Montelukast Sodium Intermediates Company Information
7.16.2 Alpha Pharmaceutical Montelukast Sodium Intermediates Product Portfolio
7.16.3 Alpha Pharmaceutical Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Alpha Pharmaceutical Main Business and Markets Served
7.16.5 Alpha Pharmaceutical Recent Developments/Updates
7.17 Kangfeidi Chemical
7.17.1 Kangfeidi Chemical Montelukast Sodium Intermediates Company Information
7.17.2 Kangfeidi Chemical Montelukast Sodium Intermediates Product Portfolio
7.17.3 Kangfeidi Chemical Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Kangfeidi Chemical Main Business and Markets Served
7.17.5 Kangfeidi Chemical Recent Developments/Updates
7.18 Anqing Rock Pharmaceutical
7.18.1 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Company Information
7.18.2 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Product Portfolio
7.18.3 Anqing Rock Pharmaceutical Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Anqing Rock Pharmaceutical Main Business and Markets Served
7.18.5 Anqing Rock Pharmaceutical Recent Developments/Updates
7.19 BioChem Partner
7.19.1 BioChem Partner Montelukast Sodium Intermediates Company Information
7.19.2 BioChem Partner Montelukast Sodium Intermediates Product Portfolio
7.19.3 BioChem Partner Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.19.4 BioChem Partner Main Business and Markets Served
7.19.5 BioChem Partner Recent Developments/Updates
7.20 Dongyue Pharma
7.20.1 Dongyue Pharma Montelukast Sodium Intermediates Company Information
7.20.2 Dongyue Pharma Montelukast Sodium Intermediates Product Portfolio
7.20.3 Dongyue Pharma Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Dongyue Pharma Main Business and Markets Served
7.20.5 Dongyue Pharma Recent Developments/Updates
7.21 WeiShi Reagent
7.21.1 WeiShi Reagent Montelukast Sodium Intermediates Company Information
7.21.2 WeiShi Reagent Montelukast Sodium Intermediates Product Portfolio
7.21.3 WeiShi Reagent Montelukast Sodium Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.21.4 WeiShi Reagent Main Business and Markets Served
7.21.5 WeiShi Reagent Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Montelukast Sodium Intermediates Industry Chain Analysis
8.2 Montelukast Sodium Intermediates Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Montelukast Sodium Intermediates Production Mode & Process Analysis
8.4 Montelukast Sodium Intermediates Sales and Marketing
8.4.1 Montelukast Sodium Intermediates Sales Channels
8.4.2 Montelukast Sodium Intermediates Distributors
8.5 Montelukast Sodium Intermediates Customer Analysis
9 Montelukast Sodium Intermediates Market Dynamics
9.1 Montelukast Sodium Intermediates Industry Trends
9.2 Montelukast Sodium Intermediates Market Drivers
9.3 Montelukast Sodium Intermediates Market Challenges
9.4 Montelukast Sodium Intermediates Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Montelukast Sodium Intermediates market is projected to grow from US$ 2363 million in 2025 to US$ 4478 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 194
USD 4900.00
(Single User License)
The global Montelukast Sodium Intermediates market size was US$ 2363 million in 2025 and is forecast to reach a readjusted size of US$ 4478 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 119
USD 4250.00
(Single User License)
The global Montelukast Sodium Intermediates market was valued at US$ 2363 million in 2025 and is anticipated to reach US$ 4478 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 163
USD 2900.00
(Single User License)
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2363 million in 2025 and is projected to reach US$ 4478 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 161
USD 3950.00
(Single User License)
Valued at US$ 2363 million in 2024, the global Montelukast Sodium Intermediates market is forecast to reach US$ 4118 million by 2030, at a CAGR of 9.7% during the forecast period.
Published Date: 2025-02-28
Pages: 193
USD 4900.00
(Single User License)
The global Montelukast Sodium Intermediates market size was US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-02-28
Pages: 115
USD 4250.00
(Single User License)
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-02-28
Pages: 155
USD 3950.00
(Single User License)
The global Montelukast Sodium Intermediates market is projected to grow from US$ 2363 million in 2025 to US$ 4478 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 194
The global Montelukast Sodium Intermediates market size was US$ 2363 million in 2025 and is forecast to reach a readjusted size of US$ 4478 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 119
The global Montelukast Sodium Intermediates market was valued at US$ 2363 million in 2025 and is anticipated to reach US$ 4478 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-03-11
Pages: 163
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2363 million in 2025 and is projected to reach US$ 4478 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-03-08
Pages: 161
Valued at US$ 2363 million in 2024, the global Montelukast Sodium Intermediates market is forecast to reach US$ 4118 million by 2030, at a CAGR of 9.7% during the forecast period.
Published: 2025-02-28
Pages: 193
The global Montelukast Sodium Intermediates market size was US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-02-28
Pages: 115
The global market for Montelukast Sodium Intermediates was estimated to be worth US$ 2154 million in 2024 and is forecast to a readjusted size of US$ 4118 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-02-28
Pages: 155
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now